Business Description
Coloplast AS
ISIN : DK0060448595
Share Class Description:
FRA:CBHD: Class BTotal Employee Number:
17,083Description
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.89 | |||||
Debt-to-EBITDA | 2.71 | |||||
Interest Coverage | 7.29 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.95 | |||||
Beneish M-Score | -3.23 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.2 | |||||
3-Year EBITDA Growth Rate | 3 | |||||
3-Year EPS without NRI Growth Rate | -1.4 | |||||
3-Year FCF Growth Rate | 7.5 | |||||
3-Year Book Growth Rate | 22.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 16.19 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.61 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.76 | |||||
9-Day RSI | 41.19 | |||||
14-Day RSI | 41.52 | |||||
3-1 Month Momentum % | -8.73 | |||||
6-1 Month Momentum % | -27.11 | |||||
12-1 Month Momentum % | -33.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.75 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 154.34 | |||||
Days Sales Outstanding | 60.61 | |||||
Days Payable | 50.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.11 | |||||
Dividend Payout Ratio | 0.98 | |||||
3-Year Dividend Growth Rate | 5 | |||||
Forward Dividend Yield % | 6.11 | |||||
5-Year Yield-on-Cost % | 7.91 | |||||
3-Year Average Share Buyback Ratio | -2 | |||||
Shareholder Yield % | 6.02 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.46 | |||||
Operating Margin % | 26.88 | |||||
Net Margin % | 7.51 | |||||
EBITDA Margin % | 31.92 | |||||
FCF Margin % | 21.12 | |||||
OCF Margin % | 27.08 | |||||
ROE % | 13.83 | |||||
ROA % | 4.37 | |||||
ROIC % | 10.52 | |||||
3-Year ROIIC % | -6.55 | |||||
ROC (Joel Greenblatt) % | 36.37 | |||||
ROCE % | 11.26 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 40.57 | |||||
Forward PE Ratio | 14.24 | |||||
PE Ratio without NRI | 16.13 | |||||
Shiller PE Ratio | 18.2 | |||||
Price-to-Owner-Earnings | 16.53 | |||||
PEG Ratio | 3.58 | |||||
PS Ratio | 3.05 | |||||
PB Ratio | 6.65 | |||||
Price-to-Free-Cash-Flow | 14.4 | |||||
Price-to-Operating-Cash-Flow | 11.24 | |||||
EV-to-EBIT | 23.59 | |||||
EV-to-Forward-EBIT | 13.01 | |||||
EV-to-EBITDA | 11.8 | |||||
EV-to-Forward-EBITDA | 10.93 | |||||
EV-to-Revenue | 3.77 | |||||
EV-to-Forward-Revenue | 3.49 | |||||
EV-to-FCF | 18.44 | |||||
Price-to-GF-Value | 0.44 | |||||
Price-to-Projected-FCF | 1.62 | |||||
Price-to-DCF (Earnings Based) | 1.17 | |||||
Price-to-DCF (FCF Based) | 1.05 | |||||
Price-to-Median-PS-Value | 0.37 | |||||
Earnings Yield (Greenblatt) % | 4.25 | |||||
FCF Yield % | 7.17 | |||||
Forward Rate of Return (Yacktman) % | 9.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coloplast AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3,755.966 | ||
| EPS (TTM) (€) | 1.252 | ||
| Beta | 0.5994 | ||
| 3-Year Sharpe Ratio | -1.16 | ||
| 3-Year Sortino Ratio | -1.31 | ||
| Volatility % | 20.57 | ||
| 14-Day RSI | 41.52 | ||
| 14-Day ATR (€) | 1.062142 | ||
| 20-Day SMA (€) | 50.9305 | ||
| 12-1 Month Momentum % | -33.33 | ||
| 52-Week Range (€) | 49.72 - 85.54 | ||
| Shares Outstanding (Mil) | 225.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coloplast AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coloplast AS Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-03 | In 155 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-05 07:30 | In 128 days | ||
| Annual report for 2026 | 2026-11-05 | In 127 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-11-05 | In 127 days | ||
| Third quarter earnings results for 2026 | 2026-08-18 07:30 | In 49 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-18 | In 48 days | ||
| DKK 5.000000 Cash Dividend | 2026-05-18 | 53.12 (-0.75%) | ||
| Second quarter earnings conference call for 2026 | 2026-05-12 11:00 | 53.80 (-0.77%) | ||
| Second quarter earnings results for 2026 | 2026-05-12 07:30 | 53.80 (-0.77%) | ||
| First quarter earnings conference call for 2026 | 2026-02-06 11:00 | 72.86 (-0.22%) |
Show
Entries
Coloplast AS Frequently Asked Questions
What is Coloplast AS(FRA:CBHD)'s stock price today?
The current price of FRA:CBHD is €49.98. The 52 week high of FRA:CBHD is €85.54 and 52 week low is €49.72.
When is next earnings date of Coloplast AS(FRA:CBHD)?
The next earnings date of Coloplast AS(FRA:CBHD) is 2026-08-18.
Does Coloplast AS(FRA:CBHD) pay dividends? If so, how much?
The Dividend Yield %  of Coloplast AS(FRA:CBHD) is 6.11% (As of Today), Highest Dividend Payout Ratio of Coloplast AS(FRA:CBHD) was 0.98. The lowest was 0.71. And the median was 0.84. The  Forward Dividend Yield % of Coloplast AS(FRA:CBHD) is 6.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Coloplast AS
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers